Thread by @MaxCollMD, 1/ Levo, Neo, Vaso oh my! Many interns worry about understanding these [...]

1/ Levo, Neo, Vaso oh my! Many interns worry about understanding these agents of the ICU/CCU. Here is a little #tweetorial #medtweetorial on a fun way to think about them, taught to me by my own senior, the pressor rainbow! Let’s #presstherainbow #medtwitter #MedStudentTwitter

2/ skip to the end for the final diagram, but don't forget as every graduation speech mentions, “Its the not the destination, It's the journey”. Before we start defending the MAP lets first look at the receptors we are going to be manipulating because #physiology is fun!

3/ Lets start with the a1 receptor, specifically those seen in the smooth muscles of our peripheral vasculature. Activation of these receptor -> activation of phopholipase C ->

release of free calcium -> smooth muscle contraction or VASOCONSTRICTION

3/ Lets start with the a1 receptor, specifically those seen in the smooth muscles of our peripheral vasculature. Activation of these receptor -> activation of phopholipase C -> release of free calcium -> smooth muscle contraction or VASOCONSTRICTION

4/ B1 receptors are primarily seen in cardiac tissue. Receptor activation ->

AC activity ->

cAMP -> cardiac myocytes to squeeze harder (inotropy) and squeeze faster (chronotropy)

Note that B2 receptors in the heart act by this exact same pathway.

4/ B1 receptors are primarily seen in cardiac tissue. Receptor activation -> AC activity -> cAMP -> cardiac myocytes to squeeze harder (inotropy) and squeeze faster (chronotropy) Note that B2 receptors in the heart act by this exact same pathway.

5/ B2 receptors though are not just found in cardiac tissue, they are also found in vascular smooth muscle. They act opposite our a1 friends from above. B1 receptor activation ->

AC activity ->

cAMP ->

MLCK -> smooth muscle relaxation or VASODILATION

5/ B2 receptors though are not just found in cardiac tissue, they are also found in vascular smooth muscle. They act opposite our a1 friends from above. B1 receptor activation -> AC activity -> cAMP -> MLCK -> smooth muscle relaxation or VASODILATION

6/ Let’s round out our receptor talk by mentioning 2 other receptors

Dopamine (D), located in splanchnic and renal circulation, causes vasodilation when activated.

Vasopressin (V1), also found in the peripheral vasculature, causes vasoconstriction when activated

7/ We got the receptors down but why are they specifically important in the roles of hemodynamic control?

Well it really comes down to two equations:

MAP=CO x SVR

CO=HR x SV

(MAP=Mean arterial pressure, CO=Cardiac Output, SVR=Systemic Vascular Resistance, SV=stroke volume)

8/ We can alter these variables by using those receptors we just used above

Activate a1 -> Vasoconstriction ->

SVR

Activate B1 ->

HR (chronotropy) and

SV (inotropy) ->

CO

Activate B2 -> Vasodilation ->

SVR

Activate V1 -> Vasoconstriction ->

SVR

9/ Understanding this #physiology we can fit our agents into categories.

1.Inopressors = ↑ inotropy (β1) + vasoconstrict (α1)
2.Inodilators = ↑ inotropy (β1) + vasodilate (β2 or D1)
3.Vasopressors = vasoconstriction (α1 or V1)

Okay time to fill out that #pressorrainbow!

10/ So starting from the far left of the diagram which of these agents have only alpha activity?

11/ Phenylephrine, a vasopressor

R: a1

Uses: refrac hypotension (not 1st line), Tachyarythmia w/ hypotension (produces reflex brady), HOCM (

SVR (afterload) helps stent open the outflow track)

Don’t use: Cardiogenic shock (pure

afterload makes it hard for

to pump

$11/ Phenylephrine, a vasopressor R: a1Uses: refrac hypotension (not 1st line), Tachyarythmia w/ hypotension (produces reflex brady), HOCM (SVR (afterload) helps stent open the outflow track)Don’t use: Cardiogenic shock (pure afterload makes it hard for to pump$

12/ Now moving clockwise on the diagram which of these agents has mainly alpha agonism but also some beta agonism?

13/ Norepinephrine, an inopressor

R: a1>b1 (will increase both SVR and CO)

Use: 1st line in septic shock

Side effects: arrhythmogenic, digital ischemia

14/ Next is Epinephrine, an inopressor

R: a1>b1>b2 (higher doses)

Use: ACLS, Anaphylaxis, Septic shock (2nd line), symptomatic bradycardia (not first line)

Side effects: arrhythmogenic, cardiac toxicity at prolonged doses

15/ Now that we have completed the left side of the rainbow let’s switch it up and start on the far right and then move counterclockwise. So which of these agents has only beta receptor agonism?

16/ Isoproterenol, an Inodilator

R: B1, B2 (

HR/CO

SVR)

Use: Bradycardia, Mg refractory torsades

Side Effects: arrhythmogenic, decreases BP, flushing

$16/ Isoproterenol, an Inodilator R: B1, B2 ( HR/CO SVR)Use: Bradycardia, Mg refractory torsadesSide Effects: arrhythmogenic, decreases BP, flushing$

17/ Next is Dobutamine, an inodilator

R: B1>B2 (

CO

SVR)

Use: Cardiogenic Shock

Side Effects: arrhythmogenic, can see tachyphylaxis as prolonged use cause downregulation of B1 receptors

17/ Next is Dobutamine, an inodilatorR: B1>B2 (CO SVR)Use: Cardiogenic Shock Side Effects: arrhythmogenic, can see tachyphylaxis as prolonged use cause downregulation of B1 receptors

18/ finally, Dopamine, an Inoconstrictor

R: B1>D1>a1 (at low-med doses), a1>B1>D1 (at high doses)

Use: symptomatic bradycardia

SE: Tachyarrhymias (Of note, SOAP-II demonstrated increase risk of adverse events compared to norepi in shock treatment)
https://pubmed.ncbi.nlm.nih.gov/20200382/

19/ That completes the main rainbow! now you may be wondering what those two blank spots are for? Well, they a for two major agents that don't fall along the rainbow because they don't act on alpha and beta receptors. Those being Vasopressin and Milrinone. Let’s discuss briefly.

20/ Vasopressin, a vassopressor (no way

)

R: V1 receptors (

SVR)

Use: Adjunct to norepi in septic shock, VAATS trial showed in subgroup of patients with less severe septic shock vaso+norepi provided mortality benefit compared to norepi alone

https://pubmed.ncbi.nlm.nih.gov/18305265/

20/ Vasopressin, a vassopressor (no way) R: V1 receptors ( SVR)Use: Adjunct to norepi in septic shock, VAATS trial showed in subgroup of patients with less severe septic shock vaso+norepi provided mortality benefit compared to norepi alone https://pubmed.ncbi.nlm.nih.gov/18305265/

21/ Milrinone already uses similar mechanisms we have talked about. It is a a Phosphodiesterase inhibitor (PDE-I).

PDE normally breaks down cAMP, but by inhibiting it we can increase the downstream signaling of cAMP, the same signaling that our Beta receptors normally cause!

22/ so to complete our rainbow

Milrinone, a inodilator and PDE-I (

CO

SVR)

Use: Cardiogenic shock, some studies ( https://pubmed.ncbi.nlm.nih.gov/9066407/ ) have demonstrated that milrinone

Pulmonary VR and thus is thought to be beneficial in RH failure

SE: arrhythmogenic

22/ so to complete our rainbowMilrinone, a inodilator and PDE-I ( CO SVR)Use: Cardiogenic shock, some studies ( https://pubmed.ncbi.nlm.nih.gov/9066407/ ) have demonstrated that milrinone Pulmonary VR and thus is thought to be beneficial in RH failureSE: arrhythmogenic

23/ and with that we have completed our pressor rainbow. Remember that the uses of of theses agents we discussed are typical for those specific clinical contexts but not hard and fast rules, you may see many of these being used in combination for certain clinical scenerios.

24/ Importance is not to memorize the indications verbatum, but understand the #physiology of these agents. With that understanding as a primer the knowledge and understanding of when to grab what agent will come. So have fun in those ICU/CCUs and get those knowledge reps in

Appreciate any feedback, edits, additions from any and all

@CPSolvers @cardionerds @runthelistpod @rabihmgeha @DxRxEdu @Dr_DanMD @AmitGoyalMD @CarineHamo @heatherkaganmd @thecurbsiders @MedTweetorials @LeivaOrly @WalkerReddM

Latest Threads Unrolled: